Author Archives : Mohan Garikiparithi

Mohan Garikiparithi got his degree in medicine from Osmania University (University of Health Sciences). He practiced clinical medicine for over a decade before he shifted his focus to the field of health communications. During his active practice he served as the head of the Dept. of Microbiology in a diagnostic centre in India. On a three-year communications program in Germany, Mohan developed a keen interest in German Medicine (Homoeopathy), and other alternative systems of medicine. He now advocates treating different medical conditions without the use of traditional drugs. An ardent squash player, Mohan believes in the importance of fitness and wellness.

Advertisement

Prozac and Paxil linked to birth defects: Study

Researchers at the U.S. Centers for Disease Control and Prevention have found that some anti-depressants taken during early pregnancy could be associated with an increased risk of birth defects. In the study, published in the British Medical Journal, researchers wanted to see if the birth defect risk affected the entire class of anti-depressant drugs known ...click here to read more

Hormone to aid in treatment of breast cancer

Although incidences of breast cancer in the U.S are on the decline, it still affects thousands of women across America. Health officials estimate that 231,840 new cases are expected to be diagnosed in 2015 alone. Typically breast cancer is treated with medications such as tamoxifen, which blocks estrogen receptors – these cause cancer cells to ...click here to read more

Advertisement

West Nile virus vaccine gets clinical trials

The National Institute of Allergy and Infectious Diseases (NIAID) has sponsored the clinical trial of a new vaccine designed to protect against West Nile virus. The experimental vaccine was originally discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University in Portland. Now, it is being tested ...click here to read more

Study points to possible dengue fever treatment

Researchers battling the deadly dengue fever have isolated the structure of a human antibody that can fight the (so far) invincible virus. Researchers at Vanderbilt University and the National University of Singapore found that a structure of the monoclonal antibody overcomes and negates the effect of the potentially lethal dengue virus. The studies were done ...click here to read more